Status:
UNKNOWN
Exercise and Vestibular Hypofunction
Lead Sponsor:
University of the Basque Country (UPV/EHU)
Collaborating Sponsors:
Bioaraba
Conditions:
Vestibular Disease
Vestibular Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Vestibular hypofunction is a heterogeneous clinical entity that arises after a vestibular pathway injury, which if not properly compensated becomes chronic, and very often disabling, presenting with p...
Detailed Description
Interventional study with two randomized groups (attention control '\[AC\] and exercise group,\[EX\]) with assessment pre and post-intervention (8 weeks) and 6 months follow-up. The AC group will per...
Eligibility Criteria
Inclusion
- Patient with bilateral or unilateral vestibular hypofunction.
- More than 6 months since the onset of vestibular hypofunction (chronic instability).
- Age over 18 years old.
- No previous rehabilitation treatment for vestibular hypofunction other than home exercises.
Exclusion
- Fluctuating instability (not present every day).
- Recent onset instability (less than 6 months old, susceptible to complete clinical recovery).
- Current neurological pathology.
- History of neurosurgical disease, cerebrovascular disease, neurodegenerative disease or with central nervous system sequelae.
- Uncorrected ocular disorders.
- History of peripheral neuropathy in the lower extremities.
- Arthropathy or motor defects in lower limbs.
- Prolonged use of sedatives or vestibular suppressant medication.
- Significant medical disorders: including uncontrolled arterial hypertension, chronic or recurrent respiratory, neuromuscular or psychiatric diseases; musculoskeletal problems that interfere with physical exercise; immunodeficient diseases or a positive HIV test; anemia, blood disorders, chronic thrombotic disorders or hypercoagulant states; malignant tumors within the last five years, with the exception of therapeutically controlled skin cancer; any other disease that may be affected or aggravated by physical exercise.
- Being pregnant or breastfeeding.
- Have plans to be out of town for more than two weeks.
Key Trial Info
Start Date :
January 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2024
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT05192564
Start Date
January 8 2022
End Date
July 30 2024
Last Update
April 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Education and Sport
Vitoria-Gasteiz, Basque Country, Spain, 01007